
Research indicates the potential of cannabis residue in reducing methane, while experts assess safety, applicability, and impacts on animal welfare

Research indicates the potential of cannabis residue in methane reduction, while experts assess safety, applicability, and animal welfare impacts

Anvisa has prohibited the manufacturing, sale, and promotion of CBD Brasil's cannabis products due to lack of sanitary authorization

Event in São Paulo brings together regulators and experts to discuss regulation, cultivation, and the market landscape of the sector

Neuropediatrician highlights the potential of full spectrum cannabidiol, but access still faces judicial and bureaucratic barriers

Evidence suggests that cannabis compounds modulate autonomic responses related to stress, anxiety, and jaw tension

The study aims to democratize knowledge, unite university, science, and field, and promote sustainable development in the region

Director-General of the National Narcotics Fund of Colombia, Milver Rojas, states that the process will be immediate once Anvisa confirms and foresees a return to the four to five-day deadline for each authorization

Statement by the President of the Chamber of Deputies occurred during a hearing with Minister Paulo Teixeira, parliamentarians, and representatives of associations on the regulation of PL 399/2015

Diagnosed with multiple sclerosis, the content creator found in the use of light cannabis and daily affection ways to reinvent her own time and rediscover lightness

According to Filipe Campos, from Close-Up International, the market could expand even further with rule updates and greater medical adherence

Dr. Juliana Bogado explains how to differentiate facts from misinformation and clarifies doubts about the safe and responsible use of cannabidiol in Brazil

Between science and sensitivity, the researcher seeks to prove that the use of cannabis can transform veterinary care and alleviate animal suffering

Regulatory agency bans commercialization and advertising of items from the brands due to lack of sanitary authorization; understand the decision and the companies' positions

Thiago Campos advocates for the extension of the regulation deadline and reinforces the importance of social listening in the process

PoderData survey reveals the highest approval rate for the therapeutic use of the plant since 2022, while rejection continues to decline

Facing the Federal Government's request for a 180-day extension to regulate cannabis, experts analyze the possible scenarios at STJ, ranging from granting the extension to imposing fines for non-compliance

Caco Ciocler reinforces the importance of discussing cannabis openly and maturely, understanding its impacts without prejudice, when commenting on his son's experience as a cannabis farmer in Canada

New formulations arrive in balanced (1:1) and isolated (300 mg) versions, focusing on quality of life, safety, and treatment customization

Debates on medicinal cannabis continue deeply at Cannabis Connection 2025 in November and at the Brazilian Medicinal Cannabis Congress in May 2026, both in São Paulo.